Hikma Pharmaceuticals (HIK) Short Positions
Add to Alert list

Active Short Positions

Holder Position Change Date
Kintbury Capital LLP 2.21% 0 15-Apr-2026 View History
Kintbury Capital LLP 1.43% 0 06-Mar-2026 View History
AQR Capital Management, LLC 0.5% 0 12-May-2025 View History

Historical Short Positions

Holder Position Change (%) Date
Marshall Wace LLP 0.77% 04-Nov-2016 View History
Pointstate Capital LP 0.55% 04-Nov-2016 View History
Marshall Wace LLP 0.68% 03-Nov-2016 View History
Coatue Management, L.L.C. 0.63% 07-Oct-2016 View History
Coatue Management, L.L.C. 0.52% 04-Oct-2016 View History
Marshall Wace LLP 0.78% 04-Oct-2016 View History
AKO Capital LLP 0.6% 28-Sep-2016 View History
AKO Capital LLP 0.5% 14-Sep-2016 View History
Marshall Wace LLP 0.8% 01-Sep-2016 View History
Marshall Wace LLP 0.77% 04-Aug-2016 View History
Marshall Wace LLP 0.69% 02-Aug-2016 View History
Marshall Wace LLP 0.53% 24-Jun-2016 View History
JPMorgan Asset Management (UK) Ltd 0.43% 21-Jun-2016 View History
JPMorgan Asset Management (UK) Ltd 0.5% 11-Apr-2016 View History
BlackRock Investment Management (UK) Limited 0.47% 08-Jul-2013 View History
BlackRock Investment Management (UK) Limited 0.59% 21-May-2013 View History
BlackRock Investment Management (UK) Limited 0.69% 09-Apr-2013 View History
BlackRock Investment Management (UK) Limited 0.73% 15-Mar-2013 View History
BlackRock Investment Management (UK) Limited 0.88% 05-Mar-2013 View History
BlackRock Investment Management (UK) Limited 1.04% 01-Mar-2013 View History
BlackRock Investment Management (UK) Limited 1.19% 25-Feb-2013 View History
BlackRock Investment Management (UK) Limited 1.25% 07-Feb-2013 View History
BlackRock Investment Management (UK) Limited 1.3% 05-Feb-2013 View History
BlackRock Investment Management (UK) Limited 1.21% 01-Nov-2012 View History

Hikma Pharmaceuticals is a British multinational pharmaceutical company, founded in 1978, that develops, manufactures, and markets a wide range of generic, branded, and in-licensed pharmaceutical products, with a focus on making high-quality medicines accessible.

Hikma share price launched at 281p in 2005.

 

Note: This description is in part generated by AI and not an endorsement by or the opinion of Investegate
UK 100

Latest directors dealings